- Country: Norway
- Summary: 2207j Not Patented Oncological Drugs, Injection Infusion, Unregistered
- NOT Ref No: 65458546
- Deadline: 20 May 2022
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 2022-304528
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Tenders are invited to 2207j not patented oncological drugs, injection infusion, unregistered
Short description: The procurement is carried out as an open tender competition and applies to purchases of various chemotherapeutics Inj injure drugs. The customers for this procurement are the four regional health trusts in Norway, Health South East RHF, Helse Vest RHF, Helse Midt-Norge RHF and Helse Nord RHF. Hospital purchases HF Division drugs carry out the acquisition on behalf of the customers.
CPV code: 33600000 - Pharmaceutical products
tender expires date: 2022-05-20 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN2207j Not Patented Oncological Drugs, Injection Infusion, Unregistered - Norway Tender
The HOSPITAL INKJ0P HF, a Government sector organization in Norway, has announced a new tender for 2207j Not Patented Oncological Drugs, Injection Infusion, Unregistered. This tender is published on NorwayTenders under NOT Ref No: 65458546 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-05-20.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
